Skip to main content
. Author manuscript; available in PMC: 2019 Jan 25.
Published in final edited form as: Ann Thorac Surg. 2018 Jul 19;106(5):1460–1467. doi: 10.1016/j.athoracsur.2018.06.022

Fig 2.

Fig 2.

(A) Kaplan-Meier survival estimates for recurrence-free survival among patients with completely resected, node-negative non-small cell lung cancer and for five pre-specified clinical risk-factors: (B) tumor size, (C) lymphovascular invasion (LVI), (D) visceral pleural invasion (VPI), (E) tumor grade, and (F) sublobar resection.